Boomer Manual and Download
PharmPK Listserv and other PK Resources
Previous Page Course Index Next Page

Explore Mechanisms

When we quantitate observations and model data we can better understand what is happening in the system under study. Correlation can be explored between the parameter values and other observations that may be collected. Table 6.3.1 provides pharmacokinetic parameters from a number of subject as well as some of the data that might be collected from a patient's hospital chart.

PK parameters and patient demographics

Table 6.3.1 Pharmacokinetic parameters and patient data

With these data we could explore some of these correlations. For example plotting the kel measured in these patient versus the clinical parameter creatinine clearance may result in a plot such as Figure 6.3.1.

Plot of kel versus creatinine clearance

Figure 6.3.1 Linear plot of observed kel versus creatinine clearance

Figure 6.3.1 suggests that there is a significant correlation between elimination of this drug and renal function as expressed by the creatinine clearance. A large fraction of the drug dose must be excreted into urine. If renal function is poor elimination would be impaired and the drug dosage regimen should be adjusted appropriately. We could also explore the relationship between apparent volume of distribution and creatinine clearance.

Volume versus creatinine clearance

Figure 6.3.2 Linear plot of apparent volume of distribution and creatinine clearance

In Figure 6.3.2 we see that there is little correlation between the apparent volume of distribution and creatinine clearance.

In another study we might look at the effect of drug dose and pharmacokinetic parameters. Some data are shown in Table 6.3.2.

Cp after three different doses

Table 6.3.2 Plasma concentrations after three different doses

Plotting these data on semi-log graph paper provides three lines with different slope and shape.

Plot of Cp versus time after three different doses

Figure 6.3.3 Semi-log plot of concentration versus time after three different doses

It would appear that these data represent nonlinear or saturable pharmacokinetics (which will be discussed in more detail in Chapter 21). A model which could explain these data are shown in Figure 6.3.4 along with a plot of AUC versus dose. This is another representation of these and more data collected after additional dose values which illustrates the nonlinear model.

AUC versus dose

Figure 6.3.3 Linear plot of AUC achieved after various doses

These and other mechanisms can be explored by modeling pharmacokinetic data.

return to the Course index

This page was last modified: Monday, 30th Oct 2017 at 6:58 pm

Privacy Statement - 25 May 2018

Material on this website should be used for Educational or Self-Study Purposes Only

iBook and pdf versions of this material and other PK material is available

Copyright © 2001-2021 David W. A. Bourne (